Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01685840 · ClinicalTrials.gov registry record · NA
Guiding Evidence Based Therapy Using Biomarker Intensified Treatment
A NA study, sponsored by Duke University.
- Terminated
- Registry status
- NA
- Development phase
- 894
- Enrollment target
NCT01685840: Clinical Trial NA study, sponsored by Duke University.
NCT01685840 is a NA study that was terminated before completion, run by Duke University. The registered enrollment target is 894 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (36% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01685840, a NA study, was terminated before completion, sponsored by Duke University.
- TERMINATED
- Registry status
- NA
- Development phase
- 894 participants
- Enrollment target
Study Summary
The primary objective is to determine the efficacy of a strategy of biomarker-guided therapy compared with usual care in high risk patients with left ventricular systolic dysfunction.
Primary Outcome
Composite of First Heart Failure Hospitalization or Cardiovascular Mortality
Interventions
- OTHER Usual Care
- DEVICE Biomarker-guided care NT-proBNP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 894 participants |
| Start Date | 2012-12 |
| Est. Completion | 2016-09-20 |
| Phase | NA |
Why NCT01685840 stopped before completion
NCT01685840 is an interventional study that assigns participants to a tested intervention. The registered 894 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (36% lower).
The record links to 0 conditions, and to 2 interventions - of which Usual Care is the first listed.
NCT01685840 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01685840 about?
NCT01685840 is a clinical study titled "Guiding Evidence Based Therapy Using Biomarker Intensified Treatment". The primary objective is to determine the efficacy of a strategy of biomarker-guided therapy compared with usual care in high risk patients with left ventricular systolic dysfunction.
What is the current status of trial NCT01685840?
This trial is currently terminated. It is a NA study. The enrollment target is 894 participants. The study started on 2012-12. Estimated completion is 2016-09-20.
What interventions are being tested in trial NCT01685840?
The interventions under investigation include: Usual Care (OTHER), Biomarker-guided care NT-proBNP (DEVICE).
Who is sponsoring clinical trial NCT01685840?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01685840's enrollment target sits among peer trials
894 130th of 2000 higher than 1,871 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04862663 · 895 participants · Phase 3
Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello-292)
- NCT05855200 · 892 participants · Phase 3
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
- NCT03564340 · 890 participants · Phase 1
Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers
- NCT02352116 · 900 participants · NA
Evaluation of Post-PACU Pain Management in Pediatric Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia